Page last updated: 2024-12-05

4-chloro-3,5-dinitrobenzoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-chloro-3,5-dinitrobenzoate: binds to cytochrome c; used chlorobenzoates because the chlorine is the reactive group; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8377
SCHEMBL ID3146159
MeSH IDM0065243

Synonyms (28)

Synonym
nsc76583
4-chloro-3,5-dinitrobenzoic acid
118-97-8
3,5-dinitro-4-chlorobenzoic acid
nsc-76583
inchi=1/c7h3cln2o6/c8-6-4(9(13)14)1-3(7(11)12)2-5(6)10(15)16/h1-2h,(h,11,12
4-chloro-3,5-dinitrobenzoic acid, 97%
benzoic acid, 4-chloro-3,5-dinitro-
einecs 204-290-1
4-chloro-3,5-dinitrobenzoate
nsc 76583
STK400545
AC-10262
AKOS000276884
benzoicacid, 4-chloro-3,5-dinitro-
FT-0618057
AM20050210
4-chloro-3,5-dinitro-benzoic acid
3,5-dinitro-4-chloro-benzoic acid
DTXSID2059481
SCHEMBL3146159
W-108528
mfcd00007080
GS-3177
3,5-dinitro-4-chlorobenzoicacid
D78268
A920164
469845UZF8
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (50.00)18.7374
1990's3 (37.50)18.2507
2000's1 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.96 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]